Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

OBJECTIVE: Long-standing evidence indicates that Alzheimer's disease patients with behavioral symptoms have a worse prognosis and a more rapid disease progression. The current retrospective analysis evaluated the efficacy and safety of memantine in a subpopulation of patients with Alzheimer�...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Wilcock, G, Ballard, C, Cooper, J, Loft, H
Materialtyp:	Journal article
Språk:	English
Publicerad:	2008

Liknande verk

Treatment benefits of memantine in moderately severe to severe Alzheimer's disease patients with behavioural symptoms
av: Wilcock, G, et al.
Publicerad: (2006)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
av: Howard, R, et al.
Publicerad: (2012)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
av: Jones, R, et al.
Publicerad: (2009)

Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
av: Dominik Glinz, et al.
Publicerad: (2019-06-01)

Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials
av: Ivana Molino, et al.
Publicerad: (2013-01-01)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
av: Wilcock, G
Publicerad: (2007)

Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer’s Disease, in Silico Trials
av: Dariusz Świetlik, et al.
Publicerad: (2022-04-01)

Donepezil for the treatment of agitation in Alzheimer's disease.
av: Howard, R, et al.
Publicerad: (2007)

Memantine for the treatment of dementia.
av: Wilcock, G
Publicerad: (2003)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
av: Giambattista Marotta, et al.
Publicerad: (2020-09-01)

SEVERE ALZHEIMER'S DISEASE PATIENTS SHOW SAFE AND SIGNIFICANT IMPROVEMENT IN 6 MONTH BRYOSTATIN TRIAL - IN THE ABSENCE OF MEMANTINE
av: Daniel Alkon
Publicerad: (2023-10-01)

The clinical use of memantine
av: Burns, A, et al.
Publicerad: (2005)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
av: Howard, R, et al.
Publicerad: (2012)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
av: Schneider, L, et al.
Publicerad: (2011)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
av: Schneider, L, et al.
Publicerad: (2011)

Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis
av: Toshi A Furukawa, et al.
Publicerad: (2019-10-01)

Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment.
av: Xiaochuan Wang, et al.
Publicerad: (2015-01-01)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
av: Wilcock, G, et al.
Publicerad: (2003)

Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer’s Disease Targeting
av: Hasan Turkez, et al.
Publicerad: (2025-02-01)

Neuroprotective effect of liraglutide and memantine in a rat model of Alzheimer’s disease
av: Bakhshwin Duaa M., et al.
Publicerad: (2024-05-01)

The ECT-AD trial for severe treatment-refractory agitation and aggression in advanced dementia: Scientific rationale and study design
av: Georgios Petrides, et al.
Publicerad: (2025-01-01)

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
av: Wilcock, G, et al.
Publicerad: (2002)

Prevalence and correlates of aggressive behaviours occurring in patients with Alzheimer's disease.
av: Eastley, R, et al.
Publicerad: (1997)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
av: Farrimond, L, et al.
Publicerad: (2012)

Clozapine to treat aggression and agitation in advanced dementia
av: A. E. Michael, et al.
Publicerad: (2024-04-01)

A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD)
av: Hee-Jin Kim, et al.
Publicerad: (2023-05-01)

Challenges and proposed solutions to conducting Alzheimer’s disease psychosis trials
av: Clive Ballard, et al.
Publicerad: (2024-05-01)

Clinical Trial Studies of Antipsychotics during Symptomatic Presentations of Agitation and/or Psychosis in Alzheimer’s Dementia: A Systematic Review
av: Haider Qasim, et al.
Publicerad: (2023-06-01)

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).
av: Ballard, C, et al.
Publicerad: (2009)

Neurobiological alteration in agitation in Alzheimer’s disease and possible interventions
av: Jagadeesh S. Rao, et al.
Publicerad: (2024-07-01)

TRANSFERRIN-FUNCTIONALIZED LIPID NANOPARTICES FOR THE DELIVERY OF MEMANTINE: A THERAPEUTIC APPROACH FOR ALZHEIMER’S DISEASE
av: Débora Nunes, et al.
Publicerad: (2023-10-01)

Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications
av: Bin‐Can Tang, et al.
Publicerad: (2023-09-01)

Managing acute agitation and aggression in the world of drug shortages
av: Jennifer Miller, PharmD, BCPP
Publicerad: (2021-11-01)

Memantine for dementia.
av: Mcshane, R, et al.
Publicerad: (2006)

Long term effect of fluoxetine and memantine on biochemical markers of Alzheimer’s disease in scopolamine-induced mice
av: N. N. H. Istifo, et al.
Publicerad: (2023-12-01)

Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients
av: Ehsan Yaghmaei, et al.
Publicerad: (2024-05-01)

Comparing IM Lorazepam and IM Clothiapine for Agitated Psychosis in Hospitalized Patients
av: •. Kverashvili, et al.
Publicerad: (2024-04-01)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
av: Wilcock, G, et al.
Publicerad: (1982)

Genetic associations with psychosis and affective disturbance in Alzheimer's disease
av: Inga Margret Antonsdottir, et al.
Publicerad: (2024-04-01)

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE
av: Wilcock, G, et al.
Publicerad: (1983)